Palforzia Will Be a New Treatment for Peanut Allergy
January 2021
Palforzia, the first FDA-approved treatment for peanut allergy, may pop up on home med lists.
Palforzia is a peanut allergen powder given orally to allergic patients 4 to 17 years old. The goal is to decrease sensitivity to small amounts of peanuts...by slowly increasing exposure.
Palforzia doesn't allow patients to freely eat peanut products...they'll still have to follow a peanut-free diet. But it may minimize an allergic reaction from accidental exposure.
Practical advice for a better career, with unlimited access to CE
Hospital Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote